Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

Hair growth-promoting nutraceuticals do not block the cancer-fighting effects of tamoxifen and may enhance its action.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Dermatological treatments can have significant side effects, including allergic reactions, sexual dysfunction, and increased cancer risk.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Combining platelet-rich plasma injections and gel may effectively treat morphea, improving skin elasticity and reducing pain.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Anti-angiogenic therapy can help treat cancer but may cause resistance and side effects, so alternative methods are being explored.

Isolated limb perfusion is a safe and effective treatment for limb melanoma.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Scaffold-based drug delivery systems improve oral cancer treatment by targeting drugs directly to cancer cells, reducing side effects.

Botulinum toxin injections effectively relieve pain from cutaneous leiomyomas.